Leucovorin Calcium 50mg Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.
If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Maintain good hydration as instructed by your doctor, especially if receiving high-dose methotrexate.
- Report any signs of infection (fever, chills) immediately.
- Report any severe diarrhea, mouth sores, or unusual bleeding/bruising.
Available Forms & Alternatives
Available Strengths:
- Leucovorin Calcium 5mg Tablets
- Leucovorin Calcium 10mg Tablets
- Leucovorin Calcium 15mg Tablets
- Leucovorin Calcium 25mg Tablets
- Leucovorin Calcium 50mg Inj, 1 Vial
- Leucovorin Calcium 100mg Inj, 1vial
- Leucovorin Calcium 350mg Inj, 1vl
- Leucovorin Calcium 500mg Inj, 1vial
- Leucovorin 10mg/ml Inj, 10ml
- Leucovorin 500mg/50ml Inj, 50ml
- Leucovorin Ca 200mg Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, which may include:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Seizures
* Severe dizziness or fainting
Other Possible Side Effects
Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience side effects that bother you or persist, contact your doctor for guidance.
Reporting Side Effects
This list is not exhaustive, and you may have questions about other potential side effects. If you do, don't hesitate to reach out to your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor is available to provide medical advice about side effects, so don't hesitate to contact them if you have any concerns.
Seek Immediate Medical Attention If You Experience:
- Severe diarrhea (especially with 5-FU combination)
- Severe mouth sores (mucositis)
- Fever or chills (signs of infection)
- Unusual bleeding or bruising
- Signs of kidney problems (decreased urination, swelling)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have anemia caused by a vitamin B12 deficiency.
If you have any stomach or bowel problems.
This list is not exhaustive, and it is crucial to discuss all your health concerns with your doctor. Additionally, provide your doctor and pharmacist with a comprehensive list of all the medications you are taking, including:
Prescription medications
Over-the-counter (OTC) medications
Natural products
* Vitamins
It is vital to verify that it is safe to take this medication with all your existing medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
Precautions & Cautions
When this medication is used in combination with fluorouracil, the risk of side effects associated with fluorouracil may increase. This may lead to more frequent, severe, or prolonged occurrences of diarrhea, mouth irritation, and mouth sores. In older adults, the combination of this medication with fluorouracil has been linked to severe bowel problems, diarrhea, and dehydration, which can be fatal. If you have any questions or concerns, discuss them with your doctor.
If you are 65 years or older, exercise caution when using this medication, as you may be more susceptible to side effects.
Prior to initiating treatment, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. It is crucial to discuss the potential benefits and risks of this medication to both you and your baby.
Some formulations of this medication may contain benzyl alcohol, which is used as a diluent. Whenever possible, avoid using products containing benzyl alcohol in newborns and infants, as high doses of benzyl alcohol can cause serious side effects in these children, particularly when combined with other medications containing benzyl alcohol. Consult your doctor to determine which diluents contain benzyl alcohol and to discuss alternative options.
Overdose Information
Overdose Symptoms:
- No specific symptoms of leucovorin overdose are known, as it is a folate derivative. However, excessive doses might theoretically reduce the efficacy of methotrexate if given inappropriately.
What to Do:
Management is generally supportive. If given inappropriately with methotrexate, it could lead to reduced methotrexate efficacy. For any suspected overdose or adverse reaction, contact a poison control center or seek immediate medical attention. Call 1-800-222-1222.
Drug Interactions
Major Interactions
- Fluorouracil (5-FU): Leucovorin significantly enhances the cytotoxicity and toxicity (e.g., myelosuppression, mucositis, diarrhea) of 5-FU. This is an intended interaction in cancer therapy, but requires careful monitoring.
- Methotrexate: Leucovorin antagonizes the effects of methotrexate. This is the intended interaction for rescue therapy, but inappropriate timing or dosing can reduce methotrexate's efficacy.
Moderate Interactions
- Folic acid antagonists (e.g., Trimethoprim, Pyrimethamine): Leucovorin can antagonize the antimicrobial effects of these drugs. This is the intended interaction for rescue from toxicity.
- Anticonvulsants (e.g., Phenytoin, Phenobarbital, Primidone): Leucovorin (folate) may decrease plasma concentrations of these drugs, potentially leading to increased seizure frequency. Monitor anticonvulsant levels.
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic status, especially important when used with myelosuppressive agents like methotrexate or 5-FU.
Timing: Prior to initiation of chemotherapy and leucovorin.
Rationale: Renal function is critical for methotrexate elimination; impairment necessitates prolonged leucovorin rescue.
Timing: Prior to high-dose methotrexate and leucovorin initiation.
Routine Monitoring
Frequency: As per protocol (e.g., 24, 48, 72 hours after methotrexate initiation, and as needed)
Target: Dependent on time point and protocol (e.g., <0.1 ยตM at 48 hours, <0.05 ยตM at 72 hours)
Action Threshold: Levels above protocol-defined thresholds require increased leucovorin dose and/or duration, and potentially other interventions (e.g., hydration, urine alkalinization, glucarpidase).
Frequency: Daily or as clinically indicated, especially during high-dose chemotherapy cycles.
Target: Within normal limits or as expected for chemotherapy-induced myelosuppression.
Action Threshold: Significant drops in cell counts (e.g., neutropenia, thrombocytopenia) may indicate excessive toxicity, requiring dose adjustments of co-administered chemotherapy or supportive care.
Frequency: Daily or as clinically indicated, especially during high-dose methotrexate protocols.
Target: Within normal limits; adequate hydration.
Action Threshold: Dehydration or electrolyte imbalances (e.g., hypokalemia) can worsen methotrexate toxicity.
Symptom Monitoring
- Signs of mucositis (oral sores, difficulty swallowing)
- Diarrhea (frequency, severity)
- Nausea and vomiting
- Skin rash
- Fever or signs of infection (due to myelosuppression)
- Signs of renal dysfunction (decreased urine output, edema)
Special Patient Groups
Pregnancy
Leucovorin is classified as Pregnancy Category C. However, its use is often critical in situations like high-dose methotrexate rescue, where the benefits of preventing severe maternal toxicity outweigh potential fetal risks. Folate is essential for fetal development, and leucovorin is a form of folate. The decision to use should be based on a careful risk-benefit assessment.
Trimester-Specific Risks:
Lactation
Leucovorin and its active metabolite (5-MTHF) are excreted into breast milk. However, as a folate derivative, it is generally considered compatible with breastfeeding, especially when used for short-term rescue. Caution is advised if the mother is receiving other cytotoxic agents in combination with leucovorin.
Pediatric Use
Dosing is typically based on body surface area (mg/mยฒ) and adjusted based on specific protocols (e.g., methotrexate levels for rescue). Pediatric patients may be more susceptible to certain toxicities when leucovorin is combined with other chemotherapeutic agents. Close monitoring is essential.
Geriatric Use
No specific dose adjustments are generally required for leucovorin based on age alone. However, elderly patients may have age-related declines in renal function, which can impact the elimination of co-administered drugs like methotrexate, necessitating prolonged leucovorin rescue. Increased susceptibility to toxicities (e.g., myelosuppression, mucositis, diarrhea) when combined with 5-FU should be considered.
Clinical Information
Clinical Pearls
- Leucovorin is NOT a folate supplement for nutritional deficiency; it is a specific antidote or chemotherapy sensitizer.
- For methotrexate rescue, leucovorin must be started within the specified timeframe (usually 24 hours after MTX initiation) and continued until methotrexate levels are below toxic thresholds.
- Oral leucovorin may not be reliably absorbed in patients with significant gastrointestinal toxicity (e.g., mucositis, vomiting) or during high-dose methotrexate rescue; IV administration is preferred in these cases.
- Ensure adequate hydration and urine alkalinization during high-dose methotrexate therapy to facilitate methotrexate excretion and reduce renal toxicity.
- When used with 5-fluorouracil, leucovorin significantly increases 5-FU's toxicity; careful monitoring for myelosuppression, mucositis, and diarrhea is crucial.
Alternative Therapies
- Glucarpidase (Voraxaze): Used for rapid reduction of toxic plasma methotrexate concentrations in patients with delayed methotrexate elimination due to impaired renal function.
- Folic acid: Not a direct substitute for leucovorin in rescue settings, as it requires reduction by dihydrofolate reductase, which is inhibited by methotrexate.